Two genetic variants in FABP1 and susceptibility to non-alcohol fatty liver disease in a Chinese population

Gene

Volumn 500, Issue 1, 2012, Pages 54-58

  Peng, Xian E ^a   Wu, Yun Li ^a   Lu, Qing Qing ^a   Hu, Zhi Jian ^a   Lin, Xu ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Case control study; FABP1; Genotype; NAFLD; Single nucleotide polymorphism

Indexed keywords

FATTY ACID BINDING PROTEIN;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BIOCHEMISTRY; CHINESE; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEPATOGRAPHY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PHYSICAL EXAMINATION; POPULATION GENETICS; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; FATTY ACID-BINDING PROTEINS; FATTY LIVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84860342480     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.03.050     Document Type: Article

References (31)

1. Adida A., Spener F. Intracellular lipid binding proteins and nuclear receptors involved in branched-chain fatty acid signaling. Prostag. Leukot Essent Fatty Acids 2002, 67:91-98.
2. Antonenkov V.D., et al. Localization of a portion of the liver isoform of fatty-acid-binding protein (L-FABP) to peroxisomes. Biochem. J. 2006, 394:475-484.
3. Atshaves B.P., McIntosh A.M., Lyuksyutova O.I., Zipfel W., Webb W.W., Schroeder F. Liver fatty acid-binding protein gene ablation inhibits branched-chain fatty acid metabolism in cultured primary hepatocytes. J. Biol. Chem. 2004, 279:30954-30965.
4. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
5. Bass N.M., Manning J.A. Tissue expression of three structurally different fatty acid binding proteins from rat heart muscle, liver, and intestine. Biochem. Biophys. Res. Commun. 1986, 137:929-935.
6. Brouillette C., Bosse Y., Perusse L., Gaudet D., Vohl M.C. Effect of liver fatty acid binding protein (FABP) T94A missense mutation on plasma lipoprotein responsiveness to treatment with fenofibrate. J. Hum. Genet. 2004, 49:424-432.
7. Desvergne B., Wahli W. Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endocr. Rev. 1999, 20:649-688.
8. Djouadi F., et al. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor alpha-deficient mice. J. Clin. Invest. 1998, 102:1083-1091.
9. Euskirchen G., et al. CREB binds to multiple loci on human chromosome 22. Mol. Cell. Biol. 2004, 24:3804-3814.
10. Fan J.G., Zhu J., Li X.J., Chen L., Li L. Prevalence of and risk factors for fatty liver in a general population of Shanghai. China. J. Hepatol. 2005, 43:508-514.
11. Fisher E., et al. L-FABP T94A is associated with fasting triglycerides and LDL-cholesterol in women. Mol. Genet. Metab. 2007, 91:278-284.
12. Francis G.A., Fayard E., Picard F., Auwerx J. Nuclear receptors and the control of metabolism. Annu. Rev. Physiol. 2003, 65:261-311.
13. Gao N., Qu X., Yan J., Huang Q., Yuan H.Y., Ouyang D.S. L-FABP T94A decreased fatty acid uptake and altered hepatic triglyceride and cholesterol accumulation in Chang liver cells stably transfected with L-FABP. Mol. Cell. Biochem. 2010, 345:207-214.
14. Guilmeau S., et al. Decreased expression of Intestinal I- and L-FABP levels in rare human genetic lipid malabsorption syndromes. Histochem. Cell Biol. 2007, 128:115-123.
15. Hotta K., et al. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease. BMC Med. Genet. 2010, 11:172.
16. Huang H., et al. Liver fatty acid-binding protein colocalizes with peroxisome proliferator activated receptor alpha and enhances ligand distribution to nuclei of living cells. Biochemistry 2004, 43:2484-2500.
17. Lake S.L., et al. Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum. Hered. 2003, 55:56-65.
18. Lehman D.M., et al. A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-d glucosaminidase is associated with type 2 diabetes in Mexican Americans. Diabetes 2005, 54:1214-1221.
19. Murphy E.J., Prows D.R., Jefferson J.R., Schroeder F. Liver fatty acid-binding protein expression in transfected fibroblasts stimulates fatty acid uptake and metabolism. Biochim. Biophys. Acta 1996, 1301:191-198.
20. Purcell S., Cherny S.S., Sham P.C. Genetic power calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.
21. Rasmussen J.T., Faergeman N.J., Kristiansen K., Knudsen J. Acyl-CoA-binding protein (ACBP) can mediate intermembrane acyl-CoA transport and donate acyl-CoA for beta-oxidation and glycerolipid synthesis. Biochem. J. 1994, 299(Pt 1):165-170.
22. Robitaille J., Brouillette C., Lemieux S., Perusse L., Gaudet D., Vohl M.C. Plasma concentrations of apolipoprotein B are modulated by a gene-diet interaction effect between the LFABP T94A polymorphism and dietary fat intake in French-Canadian men. Mol. Genet. Metab. 2004, 82:296-303.
23. Sano M., et al. Association study of calcitonin-receptor-like receptor gene in essential hypertension. Am. J. Hypertens. 2005, 18:403-408.
24. Song J., et al. Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD). FASEB J. 2005, 19:1266-1271.
25. Sookoian S., Castano G., Gianotti T.F., Gemma C., Rosselli M.S., Pirola C.J. Genetic variants in STAT3 are associated with nonalcoholic fatty liver disease. Cytokine 2008, 44:201-206.
26. Suzuki A., et al. Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J. Hepatol. 2005, 43:1060-1066.
27. Tokushige K., et al. Influence of adiponectin gene polymorphisms in Japanese patients with non-alcoholic fatty liver disease. J. Gastroenterol. 2009, 44:976-982.
28. Veerkamp J.H., van Moerkerk H.T. Fatty acid-binding protein and its relation to fatty acid oxidation. Mol. Cell. Biochem. 1993, 123:101-106.
29. Wang G., et al. Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells. Hepatology 2005, 42:871-879.
30. Zeng M.D., et al. Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. J. Dig. Dis. 2008, 9:108-112.
31. Zimmerman A.W., Veerkamp J.H. New insights into the structure and function of fatty acid-binding proteins. Cell. Mol. Life Sci. 2002, 59:1096-1116.